| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Attempting to Compensate for Reduced Neuronal Nitric Oxide Synthase Protein with Nitrate Supplementation Cannot Overcome Metabolic Dysfunction but Rather Has Detrimental Effects in Dystrophin-Deficient mdx Muscle
|
Timpani, Cara A.
|
|
2016
|
14 |
2 |
p. 429-446
|
article
|
| 2 |
Attempting to Compensate for Reduced Neuronal Nitric Oxide Synthase Protein with Nitrate Supplementation Cannot Overcome Metabolic Dysfunction but Rather Has Detrimental Effects in Dystrophin-Deficient mdx Muscle
|
Timpani, Cara A.
|
|
|
14 |
2 |
p. 429-446
|
article
|
| 3 |
Attempting to Compensate for Reduced Neuronal Nitric Oxide Synthase Protein with Nitrate Supplementation Cannot Overcome Metabolic Dysfunction but Rather Has Detrimental Effects in Dystrophin-Deficient mdx Muscle
|
Timpani, Cara A.
|
|
|
14 |
2 |
p. 429-446
|
article
|
| 4 |
Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications
|
Abou-Antoun, Tamara J.
|
|
2017
|
14 |
2 |
p. 372-384
|
article
|
| 5 |
Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications
|
Abou-Antoun, Tamara J.
|
|
|
14 |
2 |
p. 372-384
|
article
|
| 6 |
Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications
|
Abou-Antoun, Tamara J.
|
|
|
14 |
2 |
p. 372-384
|
article
|
| 7 |
Cancer of the Peripheral Nerve in Neurofibromatosis Type 1
|
Staedtke, Verena
|
|
2017
|
14 |
2 |
p. 298-306
|
article
|
| 8 |
Cancer of the Peripheral Nerve in Neurofibromatosis Type 1
|
Staedtke, Verena
|
|
|
14 |
2 |
p. 298-306
|
article
|
| 9 |
Cancer of the Peripheral Nerve in Neurofibromatosis Type 1
|
Staedtke, Verena
|
|
|
14 |
2 |
p. 298-306
|
article
|
| 10 |
Convection-Enhanced Delivery
|
Mehta, A. M.
|
|
2017
|
14 |
2 |
p. 358-371
|
article
|
| 11 |
Convection-Enhanced Delivery
|
Mehta, A. M.
|
|
|
14 |
2 |
p. 358-371
|
article
|
| 12 |
Convection-Enhanced Delivery
|
Mehta, A.M.
|
|
|
14 |
2 |
p. 358-371
|
article
|
| 13 |
Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease
|
Benoy, Veronick
|
|
2016
|
14 |
2 |
p. 417-428
|
article
|
| 14 |
Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease
|
Benoy, Veronick
|
|
|
14 |
2 |
p. 417-428
|
article
|
| 15 |
Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease
|
Benoy, Veronick
|
|
|
14 |
2 |
p. 417-428
|
article
|
| 16 |
Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease
|
Chase, Thomas N.
|
|
2017
|
14 |
2 |
p. 405-416
|
article
|
| 17 |
Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease
|
Chase, Thomas N.
|
|
|
14 |
2 |
p. 405-416
|
article
|
| 18 |
Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease
|
Chase, Thomas N.
|
|
|
14 |
2 |
p. 405-416
|
article
|
| 19 |
Early Minocycline and Late FK506 Treatment Improves Survival and Alleviates Neuroinflammation, Neurodegeneration, and Behavioral Deficits in Prion-Infected Hamsters
|
Shah, Syed Zahid Ali
|
|
2017
|
14 |
2 |
p. 463-483
|
article
|
| 20 |
Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease
|
Fishman, Paul S.
|
|
2017
|
14 |
2 |
p. 393-404
|
article
|
| 21 |
Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease
|
Fishman, Paul S.
|
|
|
14 |
2 |
p. 393-404
|
article
|
| 22 |
Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease
|
Fishman, Paul S.
|
|
|
14 |
2 |
p. 393-404
|
article
|
| 23 |
Glioma Subclassifications and Their Clinical Significance
|
Chen, Ricky
|
|
2017
|
14 |
2 |
p. 284-297
|
article
|
| 24 |
Glioma Subclassifications and Their Clinical Significance
|
Chen, Ricky
|
|
|
14 |
2 |
p. 284-297
|
article
|
| 25 |
Glioma Subclassifications and Their Clinical Significance
|
Chen, Ricky
|
|
|
14 |
2 |
p. 284-297
|
article
|
| 26 |
Lipopolysaccharide and Curcumin Co-Stimulation Potentiates Olfactory Ensheathing Cell Phagocytosis Via Enhancing Their Activation
|
Hao, Ding-Jun
|
|
2016
|
14 |
2 |
p. 502-518
|
article
|
| 27 |
Lipopolysaccharide and Curcumin Co-Stimulation Potentiates Olfactory Ensheathing Cell Phagocytosis Via Enhancing Their Activation
|
Hao, Ding-Jun
|
|
|
14 |
2 |
p. 502-518
|
article
|
| 28 |
Lipopolysaccharide and Curcumin Co-Stimulation Potentiates Olfactory Ensheathing Cell Phagocytosis Via Enhancing Their Activation
|
Hao, Ding-Jun
|
|
|
14 |
2 |
p. 502-518
|
article
|
| 29 |
Medulloblastoma: Molecular Classification-Based Personal Therapeutics
|
Archer, Tenley C.
|
|
2017
|
14 |
2 |
p. 265-273
|
article
|
| 30 |
Medulloblastoma: Molecular Classification-Based Personal Therapeutics
|
Archer, Tenley C.
|
|
|
14 |
2 |
p. 265-273
|
article
|
| 31 |
Medulloblastoma: Molecular Classification-Based Personal Therapeutics
|
Archer, Tenley C.
|
|
|
14 |
2 |
p. 265-273
|
article
|
| 32 |
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials
|
Ellingson, Benjamin M.
|
|
2017
|
14 |
2 |
p. 307-320
|
article
|
| 33 |
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials
|
Ellingson, Benjamin M.
|
|
|
14 |
2 |
p. 307-320
|
article
|
| 34 |
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials
|
Ellingson, Benjamin M.
|
|
|
14 |
2 |
p. 307-320
|
article
|
| 35 |
Neuro-Oncology: Current Concepts and Emerging Therapeutics
|
Nabors, Burt
|
|
2017
|
14 |
2 |
p. 253-255
|
article
|
| 36 |
Neuro-Oncology: Current Concepts and Emerging Therapeutics
|
Nabors, Burt
|
|
|
14 |
2 |
p. 253-255
|
article
|
| 37 |
Neuro-Oncology: Current Concepts and Emerging Therapeutics
|
Nabors, Burt
|
|
|
14 |
2 |
p. 253-255
|
article
|
| 38 |
New Directions in Anti-Angiogenic Therapy for Glioblastoma
|
Wang, Nancy
|
|
2017
|
14 |
2 |
p. 321-332
|
article
|
| 39 |
New Directions in Anti-Angiogenic Therapy for Glioblastoma
|
Wang, Nancy
|
|
|
14 |
2 |
p. 321-332
|
article
|
| 40 |
New Directions in Anti-Angiogenic Therapy for Glioblastoma
|
Wang, Nancy
|
|
|
14 |
2 |
p. 321-332
|
article
|
| 41 |
Occipital Nerve Field Transcranial Direct Current Stimulation Normalizes Imbalance Between Pain Detecting and Pain Inhibitory Pathways in Fibromyalgia
|
Ridder, Dirk De
|
|
2016
|
14 |
2 |
p. 484-501
|
article
|
| 42 |
Occipital Nerve Field Transcranial Direct Current Stimulation Normalizes Imbalance Between Pain Detecting and Pain Inhibitory Pathways in Fibromyalgia
|
De Ridder, Dirk
|
|
|
14 |
2 |
p. 484-501
|
article
|
| 43 |
Occipital Nerve Field Transcranial Direct Current Stimulation Normalizes Imbalance Between Pain Detecting and Pain Inhibitory Pathways in Fibromyalgia
|
De Ridder, Dirk
|
|
|
14 |
2 |
p. 484-501
|
article
|
| 44 |
Oncolytic Virotherapy for the Treatment of Malignant Glioma
|
Foreman, Paul M.
|
|
2017
|
14 |
2 |
p. 333-344
|
article
|
| 45 |
Oncolytic Virotherapy for the Treatment of Malignant Glioma
|
Foreman, Paul M.
|
|
|
14 |
2 |
p. 333-344
|
article
|
| 46 |
Oncolytic Virotherapy for the Treatment of Malignant Glioma
|
Foreman, Paul M.
|
|
|
14 |
2 |
p. 333-344
|
article
|
| 47 |
RETRACTED ARTICLE: Early Minocycline and Late FK506 Treatment Improves Survival and Alleviates Neuroinflammation, Neurodegeneration, and Behavioral Deficits in Prion-Infected Hamsters
|
Shah, Syed Zahid Ali
|
|
|
14 |
2 |
p. 463-483
|
article
|
| 48 |
RETRACTED ARTICLE: Early Minocycline and Late FK506 Treatment Improves Survival and Alleviates Neuroinflammation, Neurodegeneration, and Behavioral Deficits in Prion-Infected Hamsters
|
Shah, Syed Zahid Ali
|
|
|
14 |
2 |
p. 463-483
|
article
|
| 49 |
Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas
|
Vanan, Magimairajan Issai
|
|
2017
|
14 |
2 |
p. 274-283
|
article
|
| 50 |
Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas
|
Vanan, Magimairajan Issai
|
|
|
14 |
2 |
p. 274-283
|
article
|
| 51 |
Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas
|
Vanan, Magimairajan Issai
|
|
|
14 |
2 |
p. 274-283
|
article
|
| 52 |
The Copper bis(thiosemicarbazone) Complex CuII(atsm) Is Protective Against Cerebral Ischemia Through Modulation of the Inflammatory Milieu
|
Huuskonen, Mikko T.
|
|
2016
|
14 |
2 |
p. 519-532
|
article
|
| 53 |
The Copper bis(thiosemicarbazone) Complex CuII(atsm) Is Protective Against Cerebral Ischemia Through Modulation of the Inflammatory Milieu
|
Huuskonen, Mikko T.
|
|
|
14 |
2 |
p. 519-532
|
article
|
| 54 |
The Copper bis(thiosemicarbazone) Complex CuII(atsm) Is Protective Against Cerebral Ischemia Through Modulation of the Inflammatory Milieu
|
Huuskonen, Mikko T.
|
|
|
14 |
2 |
p. 519-532
|
article
|
| 55 |
Therapeutic Hypothesis Testing With Rodent Brain Tumor Models
|
Wainwright, Derek A.
|
|
2017
|
14 |
2 |
p. 385-392
|
article
|
| 56 |
Therapeutic Hypothesis Testing With Rodent Brain Tumor Models
|
Wainwright, Derek A.
|
|
|
14 |
2 |
p. 385-392
|
article
|
| 57 |
Therapeutic Hypothesis Testing With Rodent Brain Tumor Models
|
Wainwright, Derek A.
|
|
|
14 |
2 |
p. 385-392
|
article
|
| 58 |
Toward Personalized Targeted Therapeutics: An Overview
|
Weathers, Shiao-Pei S.
|
|
2016
|
14 |
2 |
p. 256-264
|
article
|
| 59 |
Toward Personalized Targeted Therapeutics: An Overview
|
Weathers, Shiao-Pei S.
|
|
|
14 |
2 |
p. 256-264
|
article
|
| 60 |
Toward Personalized Targeted Therapeutics: An Overview
|
Weathers, Shiao-Pei S.
|
|
|
14 |
2 |
p. 256-264
|
article
|
| 61 |
Tumor Vaccines for Malignant Gliomas
|
Srinivasan, Visish M.
|
|
2017
|
14 |
2 |
p. 345-357
|
article
|
| 62 |
Tumor Vaccines for Malignant Gliomas
|
Srinivasan, Visish M.
|
|
|
14 |
2 |
p. 345-357
|
article
|
| 63 |
Tumor Vaccines for Malignant Gliomas
|
Srinivasan, Visish M.
|
|
|
14 |
2 |
p. 345-357
|
article
|
| 64 |
Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration
|
Dutta, Kallol
|
|
2016
|
14 |
2 |
p. 447-462
|
article
|
| 65 |
Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration
|
Dutta, Kallol
|
|
|
14 |
2 |
p. 447-462
|
article
|
| 66 |
Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration
|
Dutta, Kallol
|
|
|
14 |
2 |
p. 447-462
|
article
|
Journal description